Cost-benefit analysis of biomarker-driven early detection of pancreatic cancer in individuals with new-onset diabetes

Irena Stefanova*, Nathan Thompson, Martyn Stott, Lucy Oldfield, Robert Hanson, Robert van der Meer, Daniel Palmer, William Greenhalf, Christopher Halloran, Eithne Costello

*Corresponding author for this work

Research output: Contribution to conferencePosterpeer-review

5 Downloads (Pure)
Filter
Active

Search results